Greg Williams
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor, UAB News
(205) 975-3914
gdw@uab.edu
Williams is responsible for helping to further burnish the national reputation of the UAB basic science enterprise, as well as for promoting novel research efforts across all university disciplines. He develops news and feature content for delivery through print and online media, and engages with social media communities formed around common interests relevant to the UAB AMC 21 Research Strategic Plan. Williams is a graduate of the Medill School of Journalism at Northwestern University, and previously worked as senior science editor at the University of Rochester Medical Center in New York State.
Beats include: Biochemistry and Molecular Genetics, Biomedical Engineering, Cell Biology, Microbiology, Physiology and Biophysics, UAB Research Foundation
(205) 975-3914
gdw@uab.edu
Williams is responsible for helping to further burnish the national reputation of the UAB basic science enterprise, as well as for promoting novel research efforts across all university disciplines. He develops news and feature content for delivery through print and online media, and engages with social media communities formed around common interests relevant to the UAB AMC 21 Research Strategic Plan. Williams is a graduate of the Medill School of Journalism at Northwestern University, and previously worked as senior science editor at the University of Rochester Medical Center in New York State.
Beats include: Biochemistry and Molecular Genetics, Biomedical Engineering, Cell Biology, Microbiology, Physiology and Biophysics, UAB Research Foundation
A new round of grand funding will allow researchers to study the HIV and tuberculosis epidemics.
The newly-renovated facility opened to improve patient health, comfort and convenience by making treatments available in one building.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent. This was the conclusion of a study presented this week at the American College of Rheumatology Scientific Sessions in Washington, D.C.
Severe sepsis strikes about 750,000 Americans each year, most of them older and often ill, with as many as half of these patients dying as septic shock shuts down their organs